In MS, mitochondria can undergo oxidative damage (Lu et al., 2000), and frataxin expression is down-regulated in initial MS lesions further indicating mitochondrial injury (Hametner et al., 2013). The gene discussed is FXN; the disease is myeloid sarcoma.